logo-loader

NetScientific says portfolio company Wanda granted two new US patents significantly extending protection for core technology

Published: 07:36 12 Dec 2017 GMT

Patents
It added that the patents are the result of research on clinical time-series data at UCLA

NetScientific PLC (LON:NSCI) has announced the issue by the US Patent and Trademark Office of two new patents exclusively licensed to its portfolio company, Wanda.

The transatlantic healthcare IP commercialisation group said the patents will significantly extend protection for the core technology used in Wanda's software application for remote health and patient management.

READ: Netscientific associate Vortex Biosciences makes first commercial sale

It added that the patents - titled, "Apparatus, System, and Method for Detecting Activities and Anomalies in Time Series Data" and "Efficient Searching of Stationary Datasets" - are the result of research on clinical time-series data at UCLA.

Commenting on the news, Francois R. Martelet, NetScientific's chief executive officer and Wanda’s chairman said: "We are delighted to announce that Wanda is further strengthening its IP, an important step in its continued corporate development.

READ: NetScientific’s Glycotest subsidiary allowed Chinese patent for liver cancer blood test

“We believe Wanda's class-leading predictive and behavioural analytics platform acts as a competitive differentiator in the emerging and highly exciting Digital Health sector."

Wanda Health discusses its recent AI developments

Wanda Health Inc CEO Tom Smith visits the Proactive London studio to speak with Thomas Warner after the Remote Patient Monitoring (RPM) company announced the start of a new fundraise. Smith gives an overview of what Wanda intends to do with the proceeds, highlighting the company's sharp focus...

on 16/1/24